Attention-Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental condition affecting both children and adults, often accompanied by sleep disturbances. For many ADHD patients, managing sleep issues requires medication, but traditional tablet and liquid formulations can present challenges. Standard tablets can be difficult to swallow, especially for younger children or individuals with sensory sensitivities. Liquid formulations also require precise dosing, increasing the risk of errors and inconsistent administration.

To address these challenges, we developed an innovative Orally Dispersible Tablet (ODT) formulation for treating sleep disorders associated with ADHD. This ODT dissolves quickly in the mouth without the need for water, offering a hassle-free, portable, and precise alternative to both traditional tablets and liquid forms. It is designed to be particularly patient-friendly for ADHD patients who may struggle with other medication administration methods.

Our ODT formulation simplifies the dosing process, enhances medication adherence, and ensures that patients receive the intended therapeutic benefit. This solution improves the overall effectiveness of sleep disorder treatment in ADHD patients while reducing barriers to consistent care. Through this innovation, we offer a more practical, convenient, and reliable solution for those managing ADHD and associated sleep challenges.